Web Images Videos Maps News Shopping Gmail more »
Help | Sign in
Go to Google Groups Home
   
Discussions for Sinovac Biotech Ltd. View all discussions
My starred discussions
My profile

  Once it goes back up to the 10-11 PPS, does anyone think it will keep going like a vrmlq or HG
 Email updates to me
All 3 messages in discussion  - 
Reporting discussion
Messages reported
The group you are posting to is a Usenet group. Messages posted to this group will make your email address visible to anyone on the Internet.
Your reply message has not been sent.
Your post was successful
 
From:
To:
Cc:
Followup To:
Add Cc | Add Followup-to | Edit Subject
Subject:
Validation:
For verification purposes please type the characters you see in the picture below or the numbers you hear by clicking the accessibility icon. Listen and type the numbers you hear
 
Terry  
View profile  
 More options Nov 7, 1:46 am
From: Terry <tgres...@gmail.com>
Date: Fri, 6 Nov 2009 22:46:57 -0800 (PST)
Local: Sat, Nov 7 2009 1:46 am
Subject: Once it goes back up to the 10-11 PPS, does anyone think it will keep going like a vrmlq or HG
Reply | Reply to author | Forward | Print | Individual message | Report this message | Find messages by this author
It's strange to me that VRMLQ went ballistic when recaf and BOCX and
some of the other new cancer discoveries don't seem to have that kind
of response in the market. Vermillion is just a test for one cancer,
recaf is a test for many many, it should go ballistic, but doesn't.
Anyone feel like educating me about what makes one different than
another. And...whats the one that has a virus that kills head and neck
cancer cells? That should be huge. They already have results of dead
tumors...That's what I read, just can't remember right now which
biotech it was..

    Reply    Reply to author    Forward  
You must Sign in before you can post messages.
To post a message you must first join this group.
Please update your nickname on the subscription settings page before posting.
You do not have the permission required to post.
lahippie  
View profile  
 More options Nov 7, 9:09 am
From: lahippie <eip...@live.com>
Date: Sat, 7 Nov 2009 06:09:10 -0800 (PST)
Local: Sat, Nov 7 2009 9:09 am
Subject: Re: Once it goes back up to the 10-11 PPS, does anyone think it will keep going like a vrmlq or HG
Reply | Reply to author | Forward | Print | Individual message | Report this message | Find messages by this author
it probably has to do with shares outstanding I couldn't find the
number on BOCX but looking at trading volume and price movement I
wouldn't be surprised if they have 100 million shares outstanding
while VRMLQ has only 6.4 million outstanding and the float is only 4.6
million shares so that makes the price more volatile and easy to
manipulate if you have the money

On Nov 7, 12:46 am, Terry <tgres...@gmail.com> wrote:


    Reply    Reply to author    Forward  
You must Sign in before you can post messages.
To post a message you must first join this group.
Please update your nickname on the subscription settings page before posting.
You do not have the permission required to post.
M.H.  
View profile  
 More options Nov 7, 9:23 am
From: "M.H." <mnshers...@gmail.com>
Date: Sat, 7 Nov 2009 06:23:21 -0800 (PST)
Local: Sat, Nov 7 2009 9:23 am
Subject: Re: Once it goes back up to the 10-11 PPS, does anyone think it will keep going like a vrmlq or HG
Reply | Reply to author | Forward | Print | Individual message | Report this message | Find messages by this author
This is a google translation of the CEO of SVA saying he is
disappointed that SVA is not priced higher....
 It says, according to Google Translate:

Set back after the SARS vaccine, Beijing Sinovac to the United States
market. In September 2003, Beijing Sinovac to reverse acquisitions
landing OTCBB market, Wei-dong is a listed platform - Bio-Technology
Co., Ltd. in Veken's CEO, one year after the Beijing Sinovac from
OTCBB to the American Stock Exchange.

"At that time has been losing money by the year 2005 began a profit,
so that time can not go in the domestic A shares." In addition, a
higher level of scientific research, industry regulation and capital
recognition is also listed on the reasons for choosing the United
States Yin Weidong. To this end, Wei-dong punched for example, "doing
the vaccine to the market, that is, to the capital, a story, in
addition to put it even better than some people can understand, can
understand." Clearly Wei-dong is lucky, because when he started in the
United States story-telling, the "subject," continued in 2003,
followed by SARS is behind the bird flu, it is now a stream.

"So I am very grateful to U.S. investors, they are agree with my
story." Vaccine R & D a long life cycle into high-risk, Wei-dong that
must have long-term perspective investors. But mentioned Beijing
Sinovac current stock price, Wei-dong is a look of dissatisfaction.
This year in May, Beijing Sinovac shares more than 2 U.S. dollars are
not satisfied when the Yin Weidong, now stands at more than 7 U.S.
dollars is still not satisfied, "because I think there is more than
this price, and now Beijing Sinovac a total value of more than 300
million U.S. dollars, ten times they turned How to. "

On Nov 7, 9:09 am, lahippie <eip...@live.com> wrote:


    Reply    Reply to author    Forward  
You must Sign in before you can post messages.
To post a message you must first join this group.
Please update your nickname on the subscription settings page before posting.
You do not have the permission required to post.

End of messages  

« Newer discussion  -  join PENNYSTOCKLIVE COM TO RECIEVE DAILY CHART ALERTS AND WEEKLY PICKS from professional traders....   Sinovac Doubles Output  -  Older discussion »




Google Home - Terms of Service - Privacy Policy

©2009 Google